Brief: Genprex CEO Commends FDA's Initiative To Accelerate Approval Process For Gene Therapies
23/03/2023 11:33
March 23 (Reuters) - Genprex Inc GNPX.O :
* GENPREX CEO COMMENDS FDA'S INITIATIVE TO ACCELERATE
APPROVAL
PROCESS FOR GENE THERAPIES
* GENPREX CEO COMMENDS FDA'S INITIATIVE TO ACCELERATE
APPROVAL
PROCESS FOR GENE THERAPIES
Source text for Eikon: ID:nPn1kctfva
Further company coverage: GNPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy